{"id":10532,"date":"2018-05-29T08:39:56","date_gmt":"2018-05-29T12:39:56","guid":{"rendered":"https:\/\/medicarereport.org\/?p=10532"},"modified":"2018-05-29T08:39:56","modified_gmt":"2018-05-29T12:39:56","slug":"benefit-change-could-raise-costs-for-patients-getting-drug-copay-assistance","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=10532","title":{"rendered":"Benefit Change Could Raise Costs For Patients Getting Drug Copay Assistance"},"content":{"rendered":"<p>(By Michelle Andrews for Kaiser Health News)<\/p>\n<p>Since Kristen Catton started taking\u00a0the drug Gilenya\u00a0two years ago, she\u2019s had only one minor relapse of her multiple sclerosis, following a bout of the flu.<\/p>\n<p>She can walk comfortably, see clearly and work part time as a nurse case manager at a hospital near her home in Columbus, Ohio. This is a big step forward; two drugs she previously tried failed to control her physical symptoms or prevent repeated flare-ups. <a href=\"https:\/\/khn.org\/news\/benefit-change-could-raise-costs-for-patients-getting-drug-copay-assistance\/?utm_campaign=KHN%3A%20First%20Edition&amp;utm_source=hs_email&amp;utm_medium=email&amp;utm_content=63306949&amp;_hsenc=p2ANqtz--cDEpUi6wd3jpM6JPb53rlmSrZlbDZJavSjJxEpqAJZbN2Fzb8Rtj0Z68Puqln9ht3n0wsp8oBi_HXnoiV954BZCZa2w&amp;_hsmi=63306949\">Continue reading article here&#8230;<\/a><\/p>\n<p style=\"margin: 0px 0px 15px; padding: 0px; outline: 0px; border: 0px currentColor; color: #444444; text-transform: none; line-height: 1.6; text-indent: 0px; letter-spacing: normal; font-family: 'Open Sans', serif; font-size: 15px; font-style: normal; font-weight: 400; word-spacing: 0px; vertical-align: baseline; white-space: normal; orphans: 2; widows: 2; font-stretch: inherit; background-color: #ffffff; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-numeric: inherit; font-variant-east-asian: inherit;\">Kaiser Health News is a nonprofit national health policy news service that is part of the nonpartisan Henry J. Kaiser Family Foundation.<\/p>\n<p style=\"margin: 0px 0px 15px; padding: 0px; outline: 0px; border: 0px currentColor; color: #444444; text-transform: none; line-height: 1.6; text-indent: 0px; letter-spacing: normal; font-family: 'Open Sans', serif; font-size: 15px; font-style: normal; font-weight: 400; word-spacing: 0px; vertical-align: baseline; white-space: normal; orphans: 2; widows: 2; font-stretch: inherit; background-color: #ffffff; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial; font-variant-numeric: inherit; font-variant-east-asian: inherit;\"><a href=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-899\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png\" sizes=\"auto, (max-width: 129px) 100vw, 129px\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-300x156.png 300w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-1024x533.png 1024w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1-390x205.png 390w, https:\/\/medicarereport.org\/wp-content\/uploads\/2015\/10\/khn-logo1.png 1600w\" alt=\"\" width=\"129\" height=\"67\" \/><\/a><\/p>\n<pre>Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>(By Michelle Andrews for Kaiser Health News) Since Kristen Catton started taking\u00a0the drug Gilenya\u00a0two years ago, she\u2019s had only one<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,15],"tags":[],"class_list":["post-10532","post","type-post","status-publish","format-standard","hentry","category-health-care-finance","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10532","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10532"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10532\/revisions"}],"predecessor-version":[{"id":10533,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/10532\/revisions\/10533"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10532"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10532"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10532"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}